Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Paradiso

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Vaccine|April 1, 1991
Mapping of a fusion related epitope of the respiratory syncytial virus fusion proteinP R Paradiso, B T Hu, R Arumugham, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Antigenic structure of the fusion glycoprotein of respiratory syncytial virusP R Paradiso, B Hu, S Hildreth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2000
Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part IW P Hausdorff, J Bryant, P R Paradiso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2000
The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part IIW P Hausdorff, J Bryant, C Kloek, et al.
The Journal of Biological Chemistry|June 25, 1989
Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virusR G Arumugham, R C Seid, S Doyle, et al.
Cell Motility|January 1, 1983
Correlation between distribution of cytoskeletal proteins and release of alkaline phosphatase-rich vesicles by epiphyseal chondrocytes in primary cultureJ E Hale, J E Chin, Y Ishikawa, et al.
Vaccine|January 1, 1993
Immunogen-induced enhanced pulmonary histopathology in the RSV cotton rat modelS W Hildreth, R R Baggs, D G Brownstein, et al.
The Journal of Infectious Diseases|February 18, 1998
Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasiaJ R Groothuis, S J King, D A Hogerman, et al.
Vaccine|January 1, 1993
Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunizationS W Hildreth, R R Baggs, D G Brownstein, et al.
Vaccine|March 1, 1991
Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV)B R Murphy, G A Prince, P L Collins, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Vaccine|April 1, 1991
Mapping of a fusion related epitope of the respiratory syncytial virus fusion proteinP R Paradiso, B T Hu, R Arumugham, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Antigenic structure of the fusion glycoprotein of respiratory syncytial virusP R Paradiso, B Hu, S Hildreth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2000
Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part IW P Hausdorff, J Bryant, P R Paradiso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2000
The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part IIW P Hausdorff, J Bryant, C Kloek, et al.
The Journal of Biological Chemistry|June 25, 1989
Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virusR G Arumugham, R C Seid, S Doyle, et al.
Cell Motility|January 1, 1983
Correlation between distribution of cytoskeletal proteins and release of alkaline phosphatase-rich vesicles by epiphyseal chondrocytes in primary cultureJ E Hale, J E Chin, Y Ishikawa, et al.
Vaccine|January 1, 1993
Immunogen-induced enhanced pulmonary histopathology in the RSV cotton rat modelS W Hildreth, R R Baggs, D G Brownstein, et al.
The Journal of Infectious Diseases|February 18, 1998
Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasiaJ R Groothuis, S J King, D A Hogerman, et al.
Vaccine|January 1, 1993
Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunizationS W Hildreth, R R Baggs, D G Brownstein, et al.
Vaccine|March 1, 1991
Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV)B R Murphy, G A Prince, P L Collins, et al.
Pageof 5